Craft

Enovis

Stock Price

$40.5

2024-10-29

Market Capitalization

$2.3 B

2024-10-29

Revenue

$2.1 B

FY, 2024

Enovis Summary

Company Summary

Overview
Enovis (formerly known as Colfax) is a medical technology company that manufactures and distributes medical devices. Its products include bone growth stimulators, vascular therapy systems, compression garments, therapeutic shoes, cervical collars, ankle bracing, etc.
Type
Public
Status
Active
Founded
1995
HQ
Wilmington, DE, US | view all locations
Website
https://enovis.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Damien McDonald

    Damien McDonald, Chief Executive Officer and Director

    • Ben Berry

      Ben Berry, Chief Financial Officer

    • Brady R. Shirley

      Brady R. Shirley, Executive Advisor and Director

      • Patricia Lang

        Patricia Lang, Senior Vice President and Chief Human Resources Officer

      Operating MetricsView all

      Countries (Production Facilities)

      11
      8.3%

      FY, 2023

      Production Facilities

      18
      5.9%

      FY, 2023

      Business Segments

      2

      FY, 2023

      LocationsView all

      13 locations detected

      • Wilmington, DE HQ

        United States

        2711 Centerville Road, Suite 400

      • Austin, TX

        United States

        9800 Metric Blvd

      • Carlsbad, CA

        United States

        5919 Sea Otter Pl Ste 200

      • Fort Worth, TX

        United States

        3300 Eagle Pkwy Ste 150

      • Lewisville, TX

        United States

        2900 Lake Vista Drive, Suite 200

      • Mequon, WI

        United States

        10300 N Enterprise Dr

      and 7 others

      Enovis Financials

      Summary Financials

      Revenue (Q1, 2025)
      $558.8M
      Gross profit (Q1, 2025)
      $332.2M
      Net income (Q1, 2025)
      ($55.7M)
      Cash (Q1, 2025)
      $38.5M
      EBIT (Q1, 2025)
      ($46.8M)
      Enterprise value
      $3.6B

      Footer menu